NIH Seeks Comments on Interinstitutional Assurance Paperwork Collection
Published Date: 9/2/2026
Notice
Summary
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the Office of Laboratory Animal Welfare (OLAW) in the Office of Extramural Research (OER) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
Analyzed Economic Effects
3 provisions identified: 0 benefits, 3 costs, 0 mixed.
Domestic PHS-funded animal-research filings
If your organization conducts PHS-funded research with vertebrate animals in the United States, you must submit Assurance (renewal or new) and an Annual Report to OLAW. The notice lists 215 Domestic Assurance respondents (30 hours per response, total 6,450 annual hours) and 841 Domestic Annual Report respondents (burden per response listed as 90/60, total 1,262 annual hours). The agency says there are no costs other than respondents' time, and OMB approval is requested for 3 years; comments are due by October 2, 2026.
Foreign PHS-funded animal-research filings
If your organization conducts PHS-funded research with vertebrate animals at foreign sites, you must submit Foreign Assurance and Foreign Annual Report forms. The notice lists 42 Foreign Assurance respondents (burden per response listed as 90/60, total 63 annual hours) and 273 Foreign Annual Report respondents (burden per response listed as 90/60, total 410 annual hours). The agency says there are no costs other than respondents' time and requests OMB approval for 3 years.
Interinstitutional performance-site assurances
Institutions listed as performance sites must submit Interinstitutional Assurance forms. The notice shows 678 Domestic Performance Site respondents (burden per response listed as 30/60, total 339 annual hours) and 35 Foreign Performance Site respondents (burden per response listed as 30/60, total 18 annual hours). The agency states there are no costs other than time and seeks OMB approval for 3 years.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-17687, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in October 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, ensuring fair and confidential decisions. Scientists applying for grants in genetics, molecular sciences, oral health, and cancer research are the ones affected, with no direct cost changes announced.
2026-17438, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings in late September 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers applying for funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
Previous / Next Documents
Previous: 2026-17898, Certain Steel Nails From the Socialist Republic of Vietnam: Final Results of the Expedited Second Sunset Review of the Countervailing Duty Order
The U.S. Department of Commerce (Commerce) finds that revocation of the countervailing duty (CVD) order on certain steel nails (nails) from the Socialist Republic of Vietnam (Vietnam) would be likely to lead to continuation or recurrence of countervailable subsidies at the levels indicated in the "Final Results of Sunset Review" section of this notice.
Next: 2026-17900, Norfolk Southern Railway Company-Abandonment Exemption-in Scioto County, Ohio